FOLH1 and neoplasm: Moreover, the aptamer-shRNA chimera functioned as a selective sensitizing agent, as it dramatically and specifically enhanced PSMA-positive tumor response to IR, therefore reducing non-specific injury of IR to health cells or tissues.